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The innate immune system is the front line of host defense against microbial infections, but its rapid and uncontrolled activation elicits microbicidal mechanisms that have deleterious effects [1, 2] . Increasing evidence indicates that the metazoan nervous system, which responds to stimuli originating from both the internal and the external environment, functions as a modulatory apparatus that controls not only microbial killing pathways but also cellular homeostatic mechanisms [3] [4] [5] . Here we report that dopamine signaling controls innate immune responses through a D1-like dopamine receptor, DOP-4, in Caenorhabditis elegans. Chlorpromazine inhibition of DOP-4 in the nervous system activates a microbicidal PMK-1/p38 mitogen-activated protein kinase signaling pathway that enhances host resistance against bacterial infections. The immune inhibitory function of dopamine originates in CEP neurons and requires active DOP-4 in downstream ASG neurons. Our findings indicate that dopamine signaling from the nervous system controls immunity in a cell-non-autonomous manner and identifies the dopaminergic system as a potential therapeutic target for not only infectious diseases but also a range of conditions that arise as a consequence of malfunctioning immune responses.
RESULTS AND DISCUSSION
The ability of an organism to survive microbial infections requires tightly controlled activation of immune responses. Excessive inflammation can lead to conditions such as Crohn's disease, rheumatoid arthritis, Alzheimer's disease, and many other diseases that involve aberrant inflammation. Indeed, to survive an infection and return to homeostasis, animals appear to rely on reflex circuits that prevent inflammation when triggered by bacterial products or inflammatory cues [6, 7] . This rapid and precise communication between the nervous and immune systems serves as an ancestral mechanism to control immune homeostasis in metazoans.
Increasing evidence highlights the importance of the vagus nerve circuit in the mediation of anti-inflammatory effects [8] . Recent studies have demonstrated that electroacupuncture requires intact sciatic and vagus nerves to inhibit inflammation by promoting the release of dopamine in the adrenal medulla [9, 10] . Dopamine is a well-characterized catecholamine neurotransmitter that is involved in diverse functions, including movement, reward, pain perception, and drug addiction [11] [12] [13] . It has also been shown to target a number of dopamine receptors in a variety of immune cells [14, 15] . However, the precise dopaminergic neural circuits potentially involved in the control of immunity remain unknown, due in part to the complexity of the nervous and immune systems of most model organisms. To dissect dopaminergic neural circuits capable of regulating immunity, we took advantage of the simple nervous system of the nematode Caenorhabditis elegans, which comprises only 302 neurons.
Recent findings indicate that several dopamine antagonists can activate a conserved PMK-1/p38 mitogen-activated protein kinase (MAPK) immune pathway in C. elegans [16] . As an initial step to determine whether drugs that target the dopaminergic nervous system may control immunity at the cell-non-autonomous level, we treated wild-type animals with the dopamine antagonist chlorpromazine during exposure to the human opportunistic pathogen Pseudomonas aeruginosa. As shown in Figure 1A , animals treated with chlorpromazine exhibited enhanced resistance to P. aeruginosa-mediated killing. In contrast, wild-type animals showed a small but significantly enhanced susceptibility to the pathogen when treated with dopamine ( Figure 1B) . We also studied whether the enhanced resistance to P. aeruginosa-mediated killing induced by treatment with chlorpromazine correlated with higher levels of active PMK-1. Western blot analysis indicated that animals treated with chlorpromazine had higher levels of active PMK-1 ( Figure 1C) . Furthermore, two genes that are markers of the PMK-1 pathway, F35E12.5 and lys-2, were upregulated in response to chlorpromazine treatment ( Figure 1D ), suggesting that chemical inhibition of dopamine signaling protects C. elegans against pathogenic bacteria by inducing the expression of immune-related genes.
Dopamine released from pre-synaptic vesicles must engage receptors expressed in downstream neurons to perform its physiological functions in vivo. To identify the dopamine receptor(s) that may be involved in the control of immune responses, we examined the susceptibility to P. aeruginosa of four strains of C. elegans lacking dopamine receptors. We found that only dop-4(tm1392) animals, which carry a 1,086-bp deletion in the dop-4 gene, showed enhanced resistance to P. aeruginosa infection compared with wild-type animals (Figures 2A and S1 ). We also found that dop-4(tm1392) animals do not show a significant lifespan extension on heat-killed bacteria compared to wild-type animals ( Figure 2B ), indicating that dop-4 may modulate immunity without affecting longevity. To rule out the possibility of an allelic effect caused by the dop-4(tm1392) mutation, we examined the susceptibility to P. aeruginosa-mediated killing of dop-4(ok1321) animals, which harbor a 1,766-bp deletion in the dop-4 locus ( Figure S1 ). Both dop-4(tm1392) and dop-4(ok1321) animals exhibited similar resistance to killing by P. aeruginosa ( Figure 2C ), suggesting that dop-4 may be involved in dopamine-mediated immune regulation. Consistent with this idea, dop-4 was required for the enhanced susceptibility to P. aeruginosa-mediated killing induced by dopamine treatment ( Figure 2D ). In addition, the enhanced resistance to P. aeruginosa-mediated killing of dop-4(tm1392) animals did not differ from that of dop-4(tm1392) animals treated with chlorpromazine ( Figure 2E ). In contrast, treatment with chlorpromazine enhanced resistance to P. aeruginosa infection in animals carrying mutations in other dopamine receptors ( Figure S2 ), suggesting that chlorpromazine enhances immunity primarily by inhibiting the D1-like dopamine receptor DOP-4.
Because avoidance to P. aeruginosa is part of the C. elegans defense response against this pathogen [17, 18] , we performed a so-called full-lawn survival assay that uses plates that are completely covered in bacteria, a condition that eliminates pathogen avoidance. We found that dop-4(tm1392) animals exhibited enhanced resistance to P. aeruginosa infection compared with wild-type animals on full-lawn plates ( Figure 2F ). In addition, we monitored the lawn occupancy of wild-type and dop-4(tm1392) animals on partial-lawn plates, which are normally used for survival assays. The nematode distribution on the pathogen lawn did not differ significantly between wildtype and dop-4(tm1392) animals ( Figure 2G ), indicating that the enhanced resistance of dop-4(tm1392) animals to P. aeruginosa infection was not due to enhanced pathogen avoidance. We further questioned whether the enhanced resistance to P. aeruginosa infection correlated with reduced bacterial accumulation in the intestine. To address this question, we infected dop-4(tm1392) animals with P. aeruginosa labeled with GFP. The dop-4(tm1392) animals showed a significant reduction of fluorescence intensity within the intestine ( Figure 2H ). In addition, there were fewer bacterial cells in the intestine of the dop-4 mutant compared with wild-type animals ( Figure 2I ). To study whether a reduced feeding behavior in dop-4(tm1392) animals may account for the reduced bacterial burden observed, we studied the pumping rate of the animals and the accumulation of fluorescent beads in the intestine. We observed that over 30 s or 2 min the pumping rate of dop-4(tm1392) animals is not lower than that of wild-type animals ( Figures S2E and  S2F ). In addition, the accumulation of fluorescent beads in the gut of dop-4(tm1392) and wild-type animals was comparable, whereas the accumulation of fluorescent beads in the feeding mutant eat-2(ad465) was lower ( Figure S2G ). These results indicate that dop-4(tm1392) animals do not exhibit any feeding deficiency and that the dose of infecting bacteria they received is comparable to that of wild-type animals. Thus, we reasoned that the dop-4 mutation leads to the activation of microbial killing mechanisms that result in reduced bacterial burden and enhanced resistance to infection.
Based on these results, we hypothesized that DOP-4 acts as a negative regulator of immunity, at least in part by inhibiting the PMK-1/p38MAPK pathway. Consistent with this idea, we observed that dop-4(tm1392) animals had higher levels of active PMK-1 compared with wild-type animals ( Figure 3A) . Inhibition of the pmk-1 gene by RNAi also completely suppressed the enhanced resistance to P. aeruginosa of dop-4(tm1392) animals ( Figure 3B ). Furthermore, PMK-1-dependent genes were upregulated in dop-4(tm1392) animals relative to wild-type animals in the absence or presence of an infection ( Figure 3C and Figure S3A ). The levels of pmk-1 in dop-4(tm1392) and wildtype animals were comparable ( Figure S3B ), indicating that DOP-4 controls PMK-1 activation rather than expression. To study the in vivo role of DOP-4 in the regulation of PMK-1, we used a transgenic transcriptional reporter strain of PMK-1 activity that expresses GFP under the control of the promoter of F35E12.5 [19] . We observed higher levels of GFP in dop-4(tm1392);PF35E12.5::gfp than in PF35E12.5::gfp animals ( Figure 3D ). We also found that animals lacking dop-4 exhibited higher levels of GFP than control animals when infected with P. aeruginosa ( Figure S3C ), indicating that DOP-4 functions as a negative regulator of immunity by preventing the expression of PMK-1-dependent genes in the intestine. It has been shown that the C. elegans transcription factor SKN-1 is activated by PMK-1 in response to stressful conditions [20] . SKN-1 is orthologous to mammalian Nrf transcription factors and functions to activate the oxidative stress response during pathogen infection [21] . Consistent with the notion that SKN-1 functions downstream of PMK-1, we found that RNAi of skn-1 also abolished the enhanced resistance of dop-4 animals ( Figure 3E ). In addition, genes controlled by SKN-1 were upregulated in dop-4(tm1392) animals ( Figure 3F ).
It has been reported that dop-4 is expressed in a series of neurons, including ASG, AVL, and pharyngeal neurons, as well as in intestinal cells [22] . To identify the tissue in which DOP-4 functions to regulate immune responses, we employed nematode strains that were engineered to promote RNAi only in neural or intestinal cells. We observed that inhibition of (H) Wild-type and dop-4(tm1392) animals were exposed to P. aeruginosa PA14-GFP for 30 hr and visualized using a Leica M165 FC fluorescence stereomicroscope. Scale bar, 0.5 mm. (I) Wild-type and dop-4(tm1392) animals were exposed to P. aeruginosa PA14-GFP for 30 hr, and the colony-forming units (CFU) were counted. Ten animals were used for each condition. All bars represent means ± SEM; *p < 0.05. See also Figure S1 for allele information and Figure S2 for additional chlorpromazine treatments and feeding behaviors.
dop-4 in the nervous system, but not in the intestine, increased the resistance of the nematodes to P. aeruginosa infection (Figures 4A and S4A ), indicating that DOP-4 functions in the nervous system to control immunity. As a first step to identify the specific dopaminergic neurons responsible for the observed immune regulation, we performed targeted killing of CEP neurons. We focused on these cells because they are the only dopaminergic neurons in C. elegans hermaphrodites that are exposed to the pseudocoelomic body fluid, from where they can directly communicate through neuroendocrine signals with tissues involved in defense responses. The killing of CEP neurons was achieved by expressing the two subunits of the C. elegans caspase CED-3 (p15 and p17) under the promoters of dat-1 and ace-1, respectively. Because the expression patterns of these two genes overlap solely in the four CEP neurons, only in these neurons could the two subunits of CED-3 form a functional module to induce programmed cell death. The ablation was conducted using strain BY250, in which all dopaminergic neurons are labeled with GFP. We observed that only CEP neurons, but not other dopaminergic neurons, were ablated, confirming the efficacy of this cell-specific killing approach ( Figure 4B ). We found that CEP(À) animals showed enhanced resistance to P. aeruginosa-mediated killing compared with control animals ( Figure 4C ). In addition, the lawn occupancy of wild-type and CEP(À) animals was comparable at different time points (Figure S4B ), which indicated that the pathogen resistance of CEP(À) animals is not due to enhanced pathogen avoidance. These data suggest that CEP neurons participate in immune modulation and that dopamine secreted from CEP neurons can induce downstream immune inhibition. Therefore, we explored whether treatment with exogenous dopamine could suppress the enhanced resistance to P. aeruginosa infection of CEP(À) animals. Indeed, CEP(À) animals treated with dopamine exhibited susceptibility to P. aeruginosa-mediated killing similar to that of wild-type animals ( Figure 4D) . No difference in the lawn occupancy of animals treated with chlorpromazine or dopamine was observed, indicating that the drugs affect immunity without altering pathogen avoidance ( Figure S4C ). We also observed that the ablation of CEP neurons could not further increase the resistance to P. aeruginosa of dop-4(tm1392) animals ( Figure 4E ). The lack of synergism between the dop-4 mutation and CEP ablation suggests that dopamine released from CEP neurons may function through the dopamine receptor DOP-4 to inhibit downstream immune pathways. In support of this idea, we found that PMK-1-dependent genes were upregulated in CEP(À) animals ( Figure 4F ). Therefore, we predicted that expression of Because ASG neurons are the only dop-4-expressing cells reported to have direct synaptic connectivity with CEP neurons, we tested whether dop-4 is required in these cells. We found that single-neuron rescue of dop-4 in ASG neurons could at least partially suppress the enhanced resistance to P. aeruginosamediated killing of dop-4 animals ( Figure 4G ).
In the present study, we have shown that dopamine signaling negatively regulates the innate immune response through a D1-like dopamine receptor, DOP-4, by downregulating the PMK-1/p38 MAPK pathway. Furthermore, a putative neural circuit involving dopaminergic CEP neurons and DOP-4-expressing ASG neurons has been shown to control the immune response against pathogen infections ( Figure 4H ). The ablation of CEP neurons conferred a similar enhanced resistance to infection, as observed in the dop-4 mutant animals. In addition, exogenous dopamine suppressed the enhanced resistance to pathogen infection caused by CEP ablation. The identification of this neural circuit and the demonstration that chemical inhibition of dopamine signaling in the nervous system can control immune pathways at the cell-non-autonomous level provide proof of concept for the use of neural interventions to control infections and conditions that involve aberrant immune functions. 
